Insulet Corp D
D
PODD
257.00
USD
6.88
(2.75%)
مغلق
حجم التداول
41,367
الربح لكل سهم
4
العائد الربحي
-
P/E
44
حجم السوق
18,082,994,422
الأخبار المقالات
العنوان: Insulet Corp
القطاع: Healthcare
الصناعة: Medical Devices
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.